Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

The U.S. Food and Drug Administration (FDA) recently approved Zepbound ... OSA symptoms while also promoting significant weight loss. Zepbound is an injectable prescription medication created ...

Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.

Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

Eli Lilly & Co. ( LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026.

Sleep expert Dr. Abhay Sharma talks about how Zepbound is now approved by the FDA for the treatment of moderate to severe ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Zyn nicotine pouches loved by young people for their appetite-suppressing effects have officially been approved in the US. The FDA said it found ... helping them lose weight, likening them to ...

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.